kryptogenin: from carp bile [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 21117640 |
| CHEMBL ID | 389341 |
| CHEBI ID | 81367 |
| MeSH ID | M0051927 |
| Synonym |
|---|
| nsc 93751 |
| 3-beta,26-dihydroxycholest-5-ene-12,22-dione [french] |
| (3-beta,25r)-3,26-dihydroxycholest-5-ene-16,22-dione |
| 3beta,26-dihydroxycholest-5-ene-16,22-dione |
| cholest-5-ene-16,22-dione, 3beta,26-dihydroxy-, (20s,25r)- |
| cholest-5-ene-16,22-dione, 3,26-dihydroxy-, (3-beta,25r)- |
| cryptogenine [french] |
| cholest-5-ene-16,22-dione, 3-beta,26-dihydroxy-, (20s,25r)- |
| cryptogenin |
| kryptogenin |
| CHEMBL389341 |
| chebi:81367 , |
| C17891 |
| LMST01010341 |
| 16,22-dioxo-25s-methyl-cholest-5-en-3beta-ol |
| cryptogenine |
| 3-beta,26-dihydroxycholest-5-ene-12,22-dione |
| bxc9x8b37j , |
| unii-bxc9x8b37j |
| GDKGOXUWEBGZBY-WQTURIIHSA-N |
| 3,26-dihydroxycholest-5-ene-16,22-dione # |
| cholest-5-ene-16,22-dione, 3,26-dihydroxy-, (3.beta.,25r)- |
| cholest-5-ene-16,22-dione, 3.beta.,26-dihydroxy-, (20s,25r)- |
| (3.beta.,25r)-3,26-dihydroxycholest-5-ene-16,22-dione |
| Q27155304 |
| AKOS040752280 |
| Class | Description |
|---|---|
| cholanoid | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID292677 | Antitumor activity against HeLa cells at 0.1 uM by MTT assay | 2007 | Bioorganic & medicinal chemistry letters, Jan-01, Volume: 17, Issue:1 | Synthesis of bisdesmosidic kryptogenyl saponins using the 'random glycosylation' strategy and evaluation of their antitumor activity. |
| AID292678 | Antitumor activity against HeLa cells at 10 nM by MTT assay | 2007 | Bioorganic & medicinal chemistry letters, Jan-01, Volume: 17, Issue:1 | Synthesis of bisdesmosidic kryptogenyl saponins using the 'random glycosylation' strategy and evaluation of their antitumor activity. |
| AID292676 | Antitumor activity against HeLa cells at 1 uM by MTT assay | 2007 | Bioorganic & medicinal chemistry letters, Jan-01, Volume: 17, Issue:1 | Synthesis of bisdesmosidic kryptogenyl saponins using the 'random glycosylation' strategy and evaluation of their antitumor activity. |
| AID292679 | Antitumor activity against HeLa cells by MTT assay | 2007 | Bioorganic & medicinal chemistry letters, Jan-01, Volume: 17, Issue:1 | Synthesis of bisdesmosidic kryptogenyl saponins using the 'random glycosylation' strategy and evaluation of their antitumor activity. |
| AID292675 | Antitumor activity against HeLa cells at 10 uM by MTT assay | 2007 | Bioorganic & medicinal chemistry letters, Jan-01, Volume: 17, Issue:1 | Synthesis of bisdesmosidic kryptogenyl saponins using the 'random glycosylation' strategy and evaluation of their antitumor activity. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||